In this morning's issue of Stock--d's newsletter they give a coverage of Optiscan's current attributes: "Relief of pathologist shortage, Benefits in inttraoperative pathology, Improving diagnosis of oral cancer, Digital pathology will replace the glass slide etc. etc."
Much, if not all has been mentioned here recently, but it's nice to have coverage from an additional source.
Dory, can you upload and post here - sorry, I'm a Luddite in these technical matters.
MM
In this morning's issue of Stock--d's newsletter they give a...
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $121.1M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.5¢ | $6.467K | 45.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 46056 | 2 |
View Market Depth
| Last trade - 12.49pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
14.0¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 13.5¢ | 14.0¢ | 13.5¢ | 6650 | ||
| Last updated 12.52pm 07/06/2024 ? | |||||
| OIL (ASX) Chart |